1Zydus Life Share Buyback: A Strategic Move for Shareholders.
Zydus Lifesciences Ltd. approves ₹600 crore share buyback at ₹1,005 per share, offering a 25% premium. 59.7 lakh equity shares, representing 0.59% of total paid-up equity capital, to be repurchased via tender offer route. Record date set for February 23, 2024, determining eligibility for participation in the buyback. Despite a slight decline in US sales, … Read more